Endu combined with concurrent chemotherapy and radiotherapy for stage IIB-IVA cervical squamous cell carcinoma patients

doi:10.12998/wjcc.v9.i27.8061

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3713)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

181

WORD

106

HTML

2070

Figures (1-1)

241

Tables (1-6)

246

Sum=2844

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

293

Download

576

Sum=869

Sep 26, 2021 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 26, 2021; 9(27): 8061-8070
Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.8061

Table 4 Comparison of the incidence of side effects between the two groups, n (%)

Toxic side effects	Test group (n = 60)		Control group (n = 60)		χ²	P value
Toxic side effects	Grade 1	Grade ≥ 2	Grade 1	Grade ≥ 2	χ²	P value
Nausea	13 (21.67)	47 (78.33)	18 (30.00)	42 (70.00)	1.087	0.297
Vomiting	19 (31.67)	41 (68.33)	24 (40.00)	36 (60.00)	0.906	0.341
Loss of appetite	24 (40.00)	36 (60.00)	20 (33.33)	40 (66.67)	0.574	0.449
Diarrhea	34 (56.67)	26 (43.33)	39 (65.00)	21 (35.00)	0.874	0.35
Neutropenia	16 (26.67)	44 (73.33)	22 (36.67)	38 (63.33)	1.386	0.239
Leukopenia	11 (18.33)	49 (81.67)	17 (28.33)	43 (71.67)	1.677	0.195
Thrombocytopenia	14 (23.33)	46 (76.67)	23 (38.33)	37 (61.67)	3.165	0.075

Citation: Zhao FJ, Su Q, Zhang W, Yang WC, Zhao L, Gao LY. Endu combined with concurrent chemotherapy and radiotherapy for stage IIB-IVA cervical squamous cell carcinoma patients. World J Clin Cases 2021; 9(27): 8061-8070
URL: https://www.wjgnet.com/2307-8960/full/v9/i27/8061.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i27.8061